Adenosinergic signaling as a target for natural killer cell immunotherapy
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Adenosinergic signaling as a target for natural killer cell immunotherapy
Authors
Keywords
Adenosinergic signaling, Cancer, Natural killer cell immunotherapy, Immunometabolism
Journal
JOURNAL OF MOLECULAR MEDICINE-JMM
Volume 96, Issue 9, Pages 903-913
Publisher
Springer Nature America, Inc
Online
2018-08-01
DOI
10.1007/s00109-018-1679-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- ATP Release Channels
- (2018) Akiyuki Taruno INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The hypoxic tumour microenvironment
- (2018) Varvara Petrova et al. Oncogenesis
- Controlling the Immune Suppressor: Transcription Factors and MicroRNAs Regulating CD73/NT5E
- (2018) Theresa Kordaß et al. Frontiers in Immunology
- Targeting adenosine in cancer immunotherapy: a review of recent progress
- (2017) Theresa L Whiteside Expert Review of Anticancer Therapy
- The ectonucleotidases CD39 and CD73: Novel checkpoint inhibitor targets
- (2017) Bertrand Allard et al. IMMUNOLOGICAL REVIEWS
- Adenosine and adenosine receptors in the immunopathogenesis and treatment of cancer
- (2017) Mohammad H. Kazemi et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Role of adenosine signaling in the pathogenesis of breast cancer
- (2017) Amirhossein Bahreyni et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Blockade of adenosine A2A receptor enhances CD8+ T cells response and decreases regulatory T cells in head and neck squamous cell carcinoma
- (2017) Si-Rui Ma et al. Molecular Cancer
- Loss of HIF-1α in natural killer cells inhibits tumour growth by stimulating non-productive angiogenesis
- (2017) Ewelina Krzywinska et al. Nature Communications
- Circulating exosomes carrying an immunosuppressive cargo interfere with cellular immunotherapy in acute myeloid leukemia
- (2017) Chang-Sook Hong et al. Scientific Reports
- What Else Can CD39 Tell Us?
- (2017) Hai Zhao et al. Frontiers in Immunology
- Multifaceted Effects of Extracellular Adenosine Triphosphate and Adenosine in the Tumor–Host Interaction and Therapeutic Perspectives
- (2017) Paola de Andrade Mello et al. Frontiers in Immunology
- A Novel Antagonist of the Immune Checkpoint Protein Adenosine A2a Receptor Restores Tumor-Infiltrating Lymphocyte Activity in the Context of the Tumor Microenvironment
- (2017) Melanie Mediavilla-Varela et al. NEOPLASIA
- CD39/CD73 upregulation on myeloid-derived suppressor cells via TGF-β-mTOR-HIF-1 signaling in patients with non-small cell lung cancer
- (2017) Jieyao Li et al. OncoImmunology
- Genetic engineering of human NK cells to express CXCR2 improves migration to renal cell carcinoma
- (2017) Veronika Kremer et al. Journal for ImmunoTherapy of Cancer
- Adenosine Activates AMPK to Phosphorylate Bcl-XL Responsible for Mitochondrial Damage and DIABLO Release in HuH-7 Cells
- (2017) Donqin Yang et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- How important is NK alloreactivity and KIR in allogeneic transplantation?
- (2016) Brian C. Shaffer et al. BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
- Co-inhibition of CD73 and A2AR Adenosine Signaling Improves Anti-tumor Immune Responses
- (2016) Arabella Young et al. CANCER CELL
- CD73–adenosine: a next-generation target in immuno-oncology
- (2016) David Allard et al. Immunotherapy
- Targeting natural killer cells in cancer immunotherapy
- (2016) Camille Guillerey et al. NATURE IMMUNOLOGY
- Targeting NK Cells for Anticancer Immunotherapy: Clinical and Preclinical Approaches
- (2016) Sebastian Carotta Frontiers in Immunology
- Molecular Mechanisms for cAMP-Mediated Immunoregulation in T cells – Role of Anchored Protein Kinase A Signaling Units
- (2016) Vanessa L. Wehbi et al. Frontiers in Immunology
- Targeting CD73 in the tumor microenvironment with MEDI9447
- (2016) Carl M. Hay et al. OncoImmunology
- Combination Approaches with Immune-Checkpoint Blockade in Cancer Therapy
- (2016) Maarten Swart et al. Frontiers in Oncology
- Adenosine Deaminase Inhibitor EHNA Exhibits a Potent Anticancer Effect Against Malignant Pleural Mesothelioma
- (2015) Yasuhiro Nakajima et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Apoptotic Cells Activate AMP-activated Protein Kinase (AMPK) and Inhibit Epithelial Cell Growth without Change in Intracellular Energy Stores
- (2015) Vimal A. Patel et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Loss of CD73-mediated actin polymerization promotes endometrial tumor progression
- (2015) Jessica L. Bowser et al. JOURNAL OF CLINICAL INVESTIGATION
- CD56brightCD16−NK Cells Produce Adenosine through a CD38-Mediated Pathway and Act as Regulatory Cells Inhibiting Autologous CD4+T Cell Proliferation
- (2015) Fabio Morandi et al. JOURNAL OF IMMUNOLOGY
- Therapeutic approaches to enhance natural killer cell cytotoxicity against cancer: the force awakens
- (2015) Richard W. Childs et al. NATURE REVIEWS DRUG DISCOVERY
- Adenosine Receptor 2A Blockade Increases the Efficacy of Anti–PD-1 through Enhanced Antitumor T-cell Responses
- (2015) Paul A. Beavis et al. Cancer Immunology Research
- Therapeutic Potential and Challenges of Natural Killer Cells in Treatment of Solid Tumors
- (2015) Andrea Gras Navarro et al. Frontiers in Immunology
- CD39: A complementary target to immune checkpoints to counteract tumor-mediated immunosuppression
- (2015) Nathalie Bonnefoy et al. OncoImmunology
- Oxygenation to improve cancer vaccines, adoptive cell transfer and blockade of immunological negative regulators
- (2015) Stephen M Hatfield et al. OncoImmunology
- Natural killer cells acquire CD73 expression upon exposure to mesenchymal stem cells
- (2014) D. Chatterjee et al. BLOOD
- Myeloid Expression of Adenosine A2A Receptor Suppresses T and NK Cell Responses in the Solid Tumor Microenvironment
- (2014) C. Cekic et al. CANCER RESEARCH
- Adenosine A2A Receptors Intrinsically Regulate CD8+ T Cells in the Tumor Microenvironment
- (2014) C. Cekic et al. CANCER RESEARCH
- Antimetastatic Effects of Blocking PD-1 and the Adenosine A2A Receptor
- (2014) D. Mittal et al. CANCER RESEARCH
- A1 adenosine receptor deficiency or inhibition reduces atherosclerotic lesions in apolipoprotein E deficient mice
- (2014) Bunyen Teng et al. CARDIOVASCULAR RESEARCH
- Adenosine Receptors: Expression, Function and Regulation
- (2014) Sandeep Sheth et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Systemic oxygenation weakens the hypoxia and hypoxia inducible factor 1α-dependent and extracellular adenosine-mediated tumor protection
- (2014) Stephen M. Hatfield et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Adenosine Inhibits Tumor Cell Invasion via Receptor-Independent Mechanisms
- (2014) S. S. Virtanen et al. MOLECULAR CANCER RESEARCH
- Targeting Cancer-Derived Adenosine:New Therapeutic Approaches
- (2014) A. Young et al. Cancer Discovery
- The Roles of CD73 in Cancer
- (2014) Zhao-wei Gao et al. Biomed Research International
- Inhibition of CD39 Enzymatic Function at the Surface of Tumor Cells Alleviates Their Immunosuppressive Activity
- (2014) J. Bastid et al. Cancer Immunology Research
- Extracellular Adenosine-Mediated Modulation of Regulatory T Cells
- (2014) Akio Ohta et al. Frontiers in Immunology
- Hypoxia downregulates the expression of activating receptors involved in NK-cell-mediated target cell killing without affecting ADCC
- (2013) Mirna Balsamo et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Blockade of A2Areceptors potently suppresses the metastasis of CD73+tumors
- (2013) Paul A. Beavis et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- CD39 and CD73 in immunity and inflammation
- (2013) Luca Antonioli et al. TRENDS IN MOLECULAR MEDICINE
- Expression and clinical significance of CD73 and hypoxia-inducible factor-1α in gastric carcinoma
- (2013) Xiao-Xia Lu WORLD JOURNAL OF GASTROENTEROLOGY
- Hypoxia-Inducible Factors in Physiology and Medicine
- (2012) Gregg L. Semenza CELL
- NK cells, hypoxia and trophoblast cell differentiation
- (2012) Damayanti Chakraborty et al. CELL CYCLE
- AMPK Is a Negative Regulator of the Warburg Effect and Suppresses Tumor Growth In Vivo
- (2012) Brandon Faubert et al. Cell Metabolism
- AMP Converted from Intracellularly Transported Adenosine Upregulates p53 Expression to Induce Malignant Pleural Mesothelioma Cell Apoptosis
- (2012) Yoshitaka Nogi et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Production of Adenosine by Ectonucleotidases: A Key Factor in Tumor Immunoescape
- (2012) François Ghiringhelli et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- High expression of CD73 as a poor prognostic biomarker in human colorectal cancer
- (2012) Xian-Rui Wu et al. JOURNAL OF SURGICAL ONCOLOGY
- ENTPD1/CD39 is a promising therapeutic target in oncology
- (2012) J Bastid et al. ONCOGENE
- Adenosine as an endogenous immunoregulator in cancer pathogenesis: where to go?
- (2012) V. Kumar Purinergic Signalling
- Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy
- (2012) Gregg L. Semenza TRENDS IN PHARMACOLOGICAL SCIENCES
- Mast Cell Adenosine Receptors Function: A Focus on the A3 Adenosine Receptor and Inflammation
- (2012) Noam Rudich et al. Frontiers in Immunology
- Autoimmune Dysregulation and Purine Metabolism in Adenosine Deaminase Deficiency
- (2012) Aisha Vanessa Sauer et al. Frontiers in Immunology
- Enhancement of tumor immunotherapy by deletion of the A2A adenosine receptor
- (2011) Adam T. Waickman et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Ectonucleotidases CD39 and CD73 on OvCA cells are potent adenosine-generating enzymes responsible for adenosine receptor 2A-dependent suppression of T cell function and NK cell cytotoxicity
- (2011) Sebastian F. M. Häusler et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- CD73-Deficient Mice Have Increased Antitumor Immunity and Are Resistant to Experimental Metastasis
- (2011) J. Stagg et al. CANCER RESEARCH
- CD73 has distinct roles in nonhematopoietic and hematopoietic cells to promote tumor growth in mice
- (2011) Long Wang et al. JOURNAL OF CLINICAL INVESTIGATION
- International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and Classification of Adenosine Receptors--An Update
- (2011) B. B. Fredholm et al. PHARMACOLOGICAL REVIEWS
- Diagnostic Value of Adenosine Deaminase Activity in Benign and Malignant Breast Tumors
- (2010) Mahmoud Aghaei et al. ARCHIVES OF MEDICAL RESEARCH
- Adenosine receptors and cancer
- (2010) Stefania Gessi et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
- The resurgence of A2B adenosine receptor signaling
- (2010) Carol M. Aherne et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
- NK cells mediate reduction of GVHD by inhibiting activated, alloreactive T cells while retaining GVT effects
- (2010) J. A. Olson et al. BLOOD
- Adenosine A2A receptors induced on iNKT and NK cells reduce pulmonary inflammation and injury in mice with sickle cell disease
- (2010) K. L. Wallace et al. BLOOD
- CD73: A Novel Target for Cancer Immunotherapy
- (2010) B. Zhang CANCER RESEARCH
- Adenosine Receptors: What We Know and What We are Learning
- (2010) M.L. Trincavelli et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- CD39/ENTPD1 Expression by CD4+Foxp3+ Regulatory T Cells Promotes Hepatic Metastatic Tumor Growth in Mice
- (2010) Xiaofeng Sun et al. GASTROENTEROLOGY
- cAMP/CREB-mediated Transcriptional Regulation of Ectonucleoside Triphosphate Diphosphohydrolase 1 (CD39) Expression
- (2010) Hui Liao et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Activation of Mast Cells by Trimeric G Protein Gi3; Coupling to the A3 Adenosine Receptor Directly and upon T Cell Contact
- (2010) D. Baram et al. JOURNAL OF IMMUNOLOGY
- Adenosine Potentiates Human Lung Mast Cell Tissue Plasminogen Activator Activity
- (2010) M. J. Sereda et al. JOURNAL OF IMMUNOLOGY
- Anti-CD73 antibody therapy inhibits breast tumor growth and metastasis
- (2010) J. Stagg et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Revisiting human natural killer cell subset function revealed cytolytic CD56dimCD16+ NK cells as rapid producers of abundant IFN- on activation
- (2010) A. De Maria et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Adenosine receptors interacting proteins (ARIPs): Behind the biology of adenosine signaling
- (2009) Francisco Ciruela et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
- Adenosine suppresses CW2 human colonic cancer growth by inducing apoptosis via A1 adenosine receptors
- (2009) Masaru Saito et al. CANCER LETTERS
- Adenosine: An endogenous modulator of innate immune system with therapeutic potential
- (2009) Vijay Kumar et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Role of Adenosine Signaling in Penile Erection and Erectile Disorders
- (2009) Prasad V. Phatarpekar et al. Journal of Sexual Medicine
- Nucleotide- and nucleoside-converting ectoenzymes: Important modulators of purinergic signalling cascade
- (2008) Gennady G. Yegutkin BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Adenosine receptors in regulation of dendritic cell differentiation and function
- (2008) S. V. Novitskiy et al. BLOOD
- Central role of Sp1-regulated CD39 in hypoxia/ischemia protection
- (2008) H. K. Eltzschig et al. BLOOD
- Modulation of murine dendritic cell function by adenine nucleotides and adenosine: Involvement of the A2B receptor
- (2008) Abduelhakem Ben Addi et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Adenosine and IFN-α synergistically increase IFN-γ production of human NK cells
- (2008) Florian Jeffe et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Arginase I Induction by Modified Lipoproteins in Macrophages: A Peroxisome Proliferator-Activated Receptor-γ/δ-Mediated Effect that Links Lipid Metabolism and Immunity
- (2008) Alejandro Gallardo-Soler et al. MOLECULAR ENDOCRINOLOGY
- Adenosine receptors: therapeutic aspects for inflammatory and immune diseases
- (2008) György Haskó et al. NATURE REVIEWS DRUG DISCOVERY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now